Long-term Qipian® administration confers resistance to airway inflammation in OVA-induced asthmatic mice
This study indicates that LTQA may confer resistance to allergic airway inflammation by modulating immune responses and gut microbiota supporting the lung-gut axis as a promising target for novel clinical approaches in asthma management.
Authors
- Ru-Yi Chen
- Yuyue Wang (ORCID: https://orcid.org/0000-0002-6598-7753)
- Jie Chen (ORCID: https://orcid.org/0000-0003-3435-0351)
- Jin-Jin Shi
- Huiying Wang
Institutions
- Ningbo University (CN)
- Second Affiliated Hospital of Zhejiang University (CN)
Publication Details
- Journal
- Frontiers in Allergy
- Published
- 2026-02-26
- DOI
- https://doi.org/10.3389/falgy.2026.1746439
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province